Digital Repository

Browsing by Subject "Carcinoma, Hepatocellular"

Browsing by Subject "Carcinoma, Hepatocellular"

Sort by: Order: Results:

  • Association of serum ferritin with diabetes and alcohol in patients with non-viral liver disease-related hepatocellular carcinoma 
    Siriwardana, R.C.; Niriella, M.A.; Dassanayake, A.S.; Ediriweera, D.; Gunetilleke, B.; Sivasundaram, T.; de Silva, H.J. (S. Karger, 2017)
    INTRODUCTION: Non-alcoholic fatty liver disease is a leading cause for hepatocellular carcinoma (HCC) in Sri Lanka. Diabetes mellitus, alcohol abuse, and liver inflammation are known to increase the risk of HCC. The present ...
  • Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis:a prospective study 
    Siriwardana, R.C.; Niriella, M.A.; Dassanayake, A.S.; Liyanage, C.; Gunetilleke, B.; Jayathunge, S.; de Silva, H.J. (Elsevier, 2015)
    BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is becoming a leading cause of chronic liver disease. Hepatocellular carcinoma (HCC) is one of its complications. Although the pathophysiology is unclear, it is reasonable ...
  • Clinical predictors of poor outcomes in hepatocellular carcinoma of nonviral aetiology 
    Siriwardana, H.D.R.C.; Niriella, M.A.; Dassanayake, A.S.; de Silva, A.P.; Gunetilleke, B.; Pathmeswaran, A.; de Silva, H.J. (Sri Lanka Medical Association, 2017)
    INTRODUCTION & OBJECTIVES: Clinical predictors for prognosis of NASH and alcohol related (non-viral) hepatocellular carcinoma (nvHCC) is poorly described. METHODS: Patients with nvHCC, from a tertiary referral hepatobiliary ...
  • Comparison of cryptogenic and hepatitis B related hepatocellular carcinoma 
    Siriwardana, R.C.; Niriella, M.A.; Dassanayake, A.S.; de Silva, A.P.; Gunetilleke, B.; Chok, K.S.H.; Lo, C.M.; Chan, S.C.; Fan, S.T.; de Silva, S.T. (Sri Lanka Medical Association, 2016)
    INTRODUCTION AND OBJECTIVES: Viral hepatitis is the leading cause for hepatocellular carcinoma (HCC) globally. Cryptogenic or non-alcoholic fatty liver related HCC is increasing and is predominant in Sri Lanka (SL). Few ...
  • Diffuse and nodular type hepatocellular carcinoma - a comparative study 
    Wickramarathne, S.D.J.; Jayarathne, V.S.; Siriwardana, R.C.; Liyanage, C.A.H.; Niriella, M.A.; Dassanayake, A.S.; Gunetilleke, M.B.; de Silva, A.P.; de Silva, H.J. (Sri lanka Medical Association, 2015)
    INTRODUCTION AND OBJECTIVES: Incidence of hepatocellular carcinoma (HCC) is increasing. Diffuse HCC (dHCC) is rare and data on such tumours are limited. METHOD: Ail consenting patients with HCC referred to Colombo North ...
  • Diffuse-Type Hepatoma: A grave prognostic marker 
    Siriwardana, R.C.; Liyanage, C.A.H.; Gunetilleke, B.; Niriella, M.A.; de Silva, H.J.; Dassanayake, A.S.; Jayatunga, S.P. (Karger Medical and Scientific Publishers, 2017)
    BACKGROUND: Data on diffuse-type hepatocellular carcinoma (HCC) are rare. HCC in Sri Lanka is rising, and the majority is related to nonalcoholic fatty liver disease. This study was planned to compare nodular- and diffuse-type ...
  • Hepatocellular carcinoma in Sri Lanka: Where do we stand? 
    Siriwardana, R.C.; Liyanage, C.A.H.L.; Jayatunge, D.S.P.; Dassanayake, A.; Gunetileke, M.G.; Niriella, M.A.; Sirigampola, C.; Upasena, A.; de Silva, H.J. (Sri Lanka Medical Association, 2013)
    INTRODUCTION AND OBJECTIVES:Hepato-cellular carcinoma (HCC) is the sixth commonest cancer worldwide. We studied 105 consecutive patients with HCC in a single tertiary care centre. METHODS: North Colombo Liver Unit maintains ...
  • Hepatocellullar carcinoma: the Sri Lankan perspective 
    Siriwardana, R. (Faculty of Medicine, University of Kelaniya, Sri Lanka, 2016)
    Ragama has become a center of excellence in the management of hepatocellular carcinoma (HCC). Since 2012 we have managed approximately 500 patients with HCC referred from different parts of the country. Sri Lanka appears ...
  • Low prevalence of Hepatitis B and C molecular markers in a cohort of Sri Lankan patients with hepatocellular carcinoma 
    Dassanayake, A.S.; Manamperi, A.; Gunawardena, N.K.; Abeyewickreme, W.; de Silva, A.P.; de Silva, H.J. (Sri Lanka Medical Association, 2007)
    INTRODUCTION: Hepatitis B (HBV) and C (HCV) infections are leading causes of hepatocellular carcinoma (HCC). Although HCV is the predominant aetiological factor in many parts of the world, HBV remains more important in ...
  • Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study 
    Siriwardana, R.C.; Thilakarathne, S.; Niriella, M.A.; Dassanayake, A.S.; Gunetilleke, M.B.; Habarakada, L.C.A.; de Silva, H.J. (BioMed Central, 2017)
    BACKGROUND: Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. METHODS: Patients with nvHCC, referred to a ...
  • Significance of pre-treatment serum alpha-fetoprotein in hepatocellular carcinoma of non-viral aetiology 
    Siriwardana, R.C.; Niriella, M.A.; Dassanayake, A.S.; de Silva, A.P.; Gunetilleke, B.; de Silva, H.J. (Sri Lanka Medical Association, 2016)
    INTRODUCTION: Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. METHOD: Patients with nvHCC, referred to a ...
  • SLHPBA Guidelines for the management of hepatocellular carcinoma in Sri Lanka - consensus statement 
    Siriwardana, R.C.; Pathirana, A.A.; Siriwardana, A.K.; Espat, N.J.; Anya Adiar (College of Surgeons of Sri Lanka, 2018)

Search Digital Repository

Browse

My Account